BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 10453029)

  • 1. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
    Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
    Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.
    Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP
    J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
    Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
    J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors.
    Punzón C; Alcaide A; Fresno M
    Int Immunopharmacol; 2003 Sep; 3(9):1293-9. PubMed ID: 12890427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.
    Aukrust P; Aandahl EM; Skålhegg BS; Nordøy I; Hansson V; Taskén K; Frøland SS; Müller F
    J Immunol; 1999 Jan; 162(2):1178-85. PubMed ID: 9916750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
    Eigler A; Matschke V; Hartmann G; Erhardt S; Boyle D; Firestein GS; Endres S
    J Leukoc Biol; 2000 Jul; 68(1):97-103. PubMed ID: 10914495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
    Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N
    Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells.
    Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ
    J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-alpha production involving the LFA-1 integrin.
    Aramburu J; Balboa MA; Rodríguez A; Melero I; Alonso M; Alonso JL; López-Botet M
    J Immunol; 1993 Oct; 151(7):3420-9. PubMed ID: 8104219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
    Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
    J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
    Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
    Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
    Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
    J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.